| Literature DB >> 22237694 |
Frans-Jasper G Wijdicks1, Olivier A J Van der Meijden, Peter J Millett, Egbert J M M Verleisdonk, R Marijn Houwert.
Abstract
BACKGROUND: The number of displaced midshaft clavicle fractures treated surgically is increasing and plate fixation is often the treatment modality of choice. The study quality and scientific levels of evidence at which possible complications of this treatment are presented vary greatly in literature. PURPOSES: The purpose of this systematic review is to assess the prevalence of complications concerning plate fixation of dislocated midshaft clavicle fractures.Entities:
Mesh:
Year: 2012 PMID: 22237694 PMCID: PMC3332382 DOI: 10.1007/s00402-011-1456-5
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 3.067
Fig. 1Flowchart demonstrating the article search and appraisal process. Search was conducted on April 6th 2011. Asterisk excluded were one case report [29] and two studies in which there was no clear distinction made between postoperative complications after acute fractures and nonunions [9, 14]. Seven studies included complicated fractures and made no distinction with uncomplicated fractures when describing complications [3, 8, 15, 18–20, 32]. One study was a surgical technique paper [2], one study only reported outcomes and no complications [28], two studies had no clear definition of indication for surgery [1, 38] and, finally, two studies included different kinds of clavicle fractures (pathological, distal and nonunions) [11, 26]
Studies graded level of evidence I according to the Oxford Centre of Evidence Based Medicine (http://www.cebm.net)
| COTS [ | Ferran et al. [ | Shen et al. [ | |
|---|---|---|---|
|
| |||
| Design | RCT; plating versus nonoperative treatment | RCT; plating versus pin fixation | RCT; ‘normal’ plating versus 3D-aided plating |
| Number of plate fixations |
|
|
|
| Type of plate (times used) | LCDCP (44), reconstruction plate (15), precontoured plate(4), Other (4) | LCDCP (15) | Reconstruction plate; ‘Normal’ plating (66), 3D-aided plating 67) |
| Plate positioning | Superior | Superior | Superior |
| Mean time to follow-up in months (range) | 12 | 12 (5–28) | 12 |
|
| |||
| Bone-healing problem | |||
| Nonunion | 2 (3%) | 0 (0%) | 8 (12%) versus 1 (1%) |
| (Symptomatic) Malunion | 0 | n/a | |
| Infection | |||
| Wound | 3 (5%) | 3 (20%) | 12 (19%) versus 2 (3%) |
| Deep | n/a | n/a | n/a |
| Implant breakage/failure/irritation | |||
| Irritation | 6 (10%) | 3 (20%) | n/a |
| Mechanical failure | n/a | n/a | n/a |
| Plate debridement/removal/revision | 6 (10%) | 8a (53%) | n/a |
| Neurovascular problems | |||
| Brachial plexus symptoms | 8 (13%) | 1 (7%) | n/a |
| Regional pain syndrome | 0 | 1 (7%) | n/a |
| Refracture after plate removal | 0 | n/a | n/a |
| Other | 4 (6%) | n/a | 0 |
RCT randomized controlled trial, LCDCP limited contact dynamic compression plate, 3D 3-dimensional, n/a not applicable (complication not mentioned in study)
aOne plate was removed because the patient was a high level athlete
Studies graded level of evidence I according to the Oxford Centre of Evidence Based Medicine (http://www.cebm.net)
| Kuhlshrestha et al. [ | |
|---|---|
|
| |
| Design | Prospective cohort; plating versus nonoperative treatment |
| Number of plate fixations |
|
| Type of plate (times used) | Reconstruction plate (45) |
| Plate positioning | Superior (15), anterior inferior (30) |
| Mean time to follow-up in months (range) | 12 |
|
| |
| Bone-healing problem | |
| Nonunion | 0 |
| (Symptomatic) Malunion | 2 (4%) |
| Infection | |
| Wound | n/a |
| Deep | n/a |
| Implant breakage/failure/irritation | |
| Irritation | 4 (9%) |
| Mechanical failure | n/a |
| Plate debridement/removal/revision | 4 (9%) |
| Neurovascular problems | |
| Brachial plexus symptoms | n/a |
| Regional pain syndrome | n/a |
| Refracture after plate removal | 0 |
| Other | 4 (9%) |
n/a not applicable (complication not mentioned in study)
Studies graded level of evidence III according to the Oxford Centre of Evidence Based Medicine (http://www.cebm.net)
| Vanbeek et al. [ | Cho et al. [ | Liu et al. [ | |
|---|---|---|---|
|
| |||
| Design | Retrospective cohort study; noncontoured plating versus contoured plating | Retrospective cohort study; reconstruction plating versus reconstruction locking plating | Retrospective cohort study; plating versus pin fixation |
| Number of plate fixations |
|
|
|
| Type of plate (times used) | Noncontoured (14); DCP (4), LCP (2), LCDCP (4), reconstruction plate (4), precontoured (28); locking clavicle plate (28) | Precontoured; reconstruction plate (19), reconstruction LCP (22) | Reconstruction LCP (59) |
| Plate positioning | Superior | Superior | Superior |
| Mean time to follow-up in months (range) | 12 | 13 (7–35) versus 12 (7–24) | 12 |
|
| |||
| Bone-healing problem | |||
| Nonunion | 0 versus 1 (4%) | 0 | 6 (10%) |
| (Symptomatic) Malunion | n/a | 0 | 2 (3%) |
| Infection | |||
| Wound | 0 versus 1 (4%) | 0 | 6 (10%) |
| Deep | n/a | 0 | |
| Implant breakage/failure/irritation | |||
| Irritation | 9 (64%)a versus 9 (32%) | 0 | 12 (20%) |
| Mechanical failure | n/a | 0 | 4 (8%) |
| Plate debridement/removal/revision | 3 (21%) versus 3 (11%) | n/a | 14 (24%) |
| Neurovascular problems | |||
| Brachial plexus symptoms | n/a | n/a | n/a |
| Regional pain syndrome | n/a | 2 (11%) versus 1 (5%) | n/a |
| Refracture after plate removal | 0 versus 1 (4%) | 0 | n/a |
| Other | 0 versus 2 (7%) | 7 (39%) versus 5 (23%) | n/a |
LCDCP limited contact dynamic compression plate, n/a not applicable (complication not mentioned in study)
aRemoved noncontoured plates included DCP (1), LCDCP (1) and reconstruction plate (1)
Studies graded level of evidence IV according to the Oxford Centre of Evidence Based Medicine (http://www.cebm.net)
| Russo et al. [ | Verborgt et al. [ | Böstman et al. [ | |
|---|---|---|---|
|
| |||
| Design | Retrospective case series | Retrospective case series | Retrospective case series |
| Number of plate fixations |
|
|
|
| Type of plate (times used) | Mennen-plate | Precontoured; reconstruction plate (?) LCDCP (?) | DCP (57), reconstruction plate (46) |
| Plate positioning | Superior | Anterior | Anterior (57) Superior (46) |
| Mean time to follow-up in months (range) | 12 | 3 | 23 (6–53) |
|
| |||
| Bone-healing problem | |||
| Nonunion | 2 (5%) | 2 (5%) | 3 (3%) |
| (Symptomatic) Malunion | n/a | n/a | 12 (12%) |
| Infection | |||
| Wound | 0 | 4 (10%) | 3 (3%) |
| Deep | 0 | 3 (8%) | 5 (5%) |
| Implant breakage/failure/irritation | |||
| Irritation | 0 | n/a | n/a |
| Mechanical failure | 0 | 2 (5%) | 16 (16%) |
| Plate debridement/removal/revision | 13a (30%) | 7 (18%) | 14 (14%) + 54 (52%)b |
| Neurovascular problems | |||
| Brachial plexus symptoms | 10 (23%) | 3 (8%) | 2 (2%) |
| Regional pain syndrome | n/a | n/a | n/a |
| Refracture after plate removal | n/a | 2 (5%)c | 1 (1%) |
| Other | 2 (5%) | n/a | n/a |
LCDCP low contact dynamic compression plate, DCP dynamic compression plate, n/a not applicable (complication not mentioned in study)
a11 patients requested removal of the plate for cosmetic reasons
b54 patients underwent routine plate removal
cRefractures both after LCDCP plates
Quality assessment outcome of all analyzed studies according to the modified version of the Cochrane Bone, Joint and Muscle Trauma Group’s former quality assessment tool (QAT, http://www.cochrane-handbook.com)
| Study | Allocation concealment | Intention- to-treat analysis | Assessor blinding | Comparable baseline characteristics | Participant blinding | Treatment provider blinding | Care program comparability | Defined in - and exclusion criteria |
|---|---|---|---|---|---|---|---|---|
| COTS et al. [ | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 2 |
| Kulshrestva et al. [ | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 2 |
| Ferran et al. [ | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 2 |
| Shen et al. [ | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 1 |
| Liu et al. [ | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 2 |
| Cho et al. [ | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 1 |
| Vanbeek et al. [ | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 2 |
| Russo et al. [ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Bostman et al. [ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Thyagarajan et al. [ | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 |
| Verborgt et al. [ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Bold values indicate that the higher the value, the better methodological quality and least chance of bias, with a maximum score of 24
QAT quality assessment tool